WO1995011967A1 - Zygote viable - Google Patents
Zygote viable Download PDFInfo
- Publication number
- WO1995011967A1 WO1995011967A1 PCT/EP1994/003485 EP9403485W WO9511967A1 WO 1995011967 A1 WO1995011967 A1 WO 1995011967A1 EP 9403485 W EP9403485 W EP 9403485W WO 9511967 A1 WO9511967 A1 WO 9511967A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- zygote
- dna
- gamete
- treated
- paternal
- Prior art date
Links
- 230000008775 paternal effect Effects 0.000 claims abstract description 21
- 210000000349 chromosome Anatomy 0.000 claims abstract description 19
- 230000008774 maternal effect Effects 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000013611 chromosomal DNA Substances 0.000 claims abstract description 13
- 230000000394 mitotic effect Effects 0.000 claims abstract description 10
- 230000004720 fertilization Effects 0.000 claims abstract description 9
- 230000032823 cell division Effects 0.000 claims abstract description 5
- 239000000138 intercalating agent Substances 0.000 claims abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 28
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 21
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical group C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 claims description 18
- 210000004027 cell Anatomy 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 230000015556 catabolic process Effects 0.000 claims description 12
- 238000006731 degradation reaction Methods 0.000 claims description 12
- 239000012634 fragment Substances 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 230000001965 increasing effect Effects 0.000 claims description 8
- 239000003550 marker Substances 0.000 claims description 7
- 230000001939 inductive effect Effects 0.000 claims description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 claims description 4
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims description 4
- 239000004009 herbicide Substances 0.000 claims description 4
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 claims description 4
- 102000053187 Glucuronidase Human genes 0.000 claims description 3
- 108010060309 Glucuronidase Proteins 0.000 claims description 3
- 230000000593 degrading effect Effects 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108060001084 Luciferase Proteins 0.000 claims description 2
- 239000005089 Luciferase Substances 0.000 claims description 2
- 239000005587 Oryzalin Substances 0.000 claims description 2
- BGLGAKMTYHWWKW-UHFFFAOYSA-N acridine yellow Chemical compound [H+].[Cl-].CC1=C(N)C=C2N=C(C=C(C(C)=C3)N)C3=CC2=C1 BGLGAKMTYHWWKW-UHFFFAOYSA-N 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 229960001338 colchicine Drugs 0.000 claims description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 claims description 2
- 229960005542 ethidium bromide Drugs 0.000 claims description 2
- 230000002363 herbicidal effect Effects 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 229960001428 mercaptopurine Drugs 0.000 claims description 2
- VHEWQRWLIDWRMR-UHFFFAOYSA-N n-[methoxy-(4-methyl-2-nitrophenoxy)phosphinothioyl]propan-2-amine Chemical group CC(C)NP(=S)(OC)OC1=CC=C(C)C=C1[N+]([O-])=O VHEWQRWLIDWRMR-UHFFFAOYSA-N 0.000 claims description 2
- LZGUHMNOBNWABZ-UHFFFAOYSA-N n-nitro-n-phenylnitramide Chemical compound [O-][N+](=O)N([N+]([O-])=O)C1=CC=CC=C1 LZGUHMNOBNWABZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000001272 nitrous oxide Substances 0.000 claims description 2
- UNAHYJYOSSSJHH-UHFFFAOYSA-N oryzalin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(S(N)(=O)=O)C=C1[N+]([O-])=O UNAHYJYOSSSJHH-UHFFFAOYSA-N 0.000 claims description 2
- 210000004681 ovum Anatomy 0.000 claims description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 claims description 2
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 claims description 2
- 230000033616 DNA repair Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000011278 mitosis Effects 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
- 230000000295 complement effect Effects 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 description 17
- 235000013601 eggs Nutrition 0.000 description 10
- 210000002257 embryonic structure Anatomy 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 210000001161 mammalian embryo Anatomy 0.000 description 7
- 230000010152 pollination Effects 0.000 description 7
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 6
- 238000003306 harvesting Methods 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 230000010354 integration Effects 0.000 description 4
- 235000021536 Sugar beet Nutrition 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 206010068051 Chimerism Diseases 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 108010044467 Isoenzymes Proteins 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- -1 acridine compound Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- GSCPDZHWVNUUFI-UHFFFAOYSA-N 3-aminobenzamide Chemical compound NC(=O)C1=CC=CC(N)=C1 GSCPDZHWVNUUFI-UHFFFAOYSA-N 0.000 description 1
- 102000009062 ADP Ribose Transferases Human genes 0.000 description 1
- 108010049290 ADP Ribose Transferases Proteins 0.000 description 1
- 108010009924 Aconitate hydratase Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102100039868 Cytoplasmic aconitate hydratase Human genes 0.000 description 1
- 102000008158 DNA Ligase ATP Human genes 0.000 description 1
- 108010060248 DNA Ligase ATP Proteins 0.000 description 1
- 239000012623 DNA damaging agent Substances 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000008722 morphological abnormality Effects 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 230000000270 postfertilization Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000013278 single fertilization Effects 0.000 description 1
- 230000005783 single-strand break Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8206—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
Definitions
- the present invention relates to the production of novel organisms, and in particular to the production of transformed plants.
- the present invention substantially overcomes this disadvantage.
- viable zygote in which chromosomal DNA from one of the parental gametes has been substantially degraded.
- viable zygote is meant the fusion product of a maternal and paternal gamete, which product is capable of undergoing mitotic cell division when exposed to a suitable environment (in vivo, in vitro, ex vivo, or in uter ⁇ ). It is preferred that at least some of the degraded DNA from one of the gametes is incorporated into the chromosomes of the other gamete.
- the degradation preferably involves the introduction into the DNA of both double and single strand breaks.
- the DNA may be degraded to the extent that chromosome fragments remain, or it may be somewhat more degraded, for example to the extent that transcribable gene fragments do not remain.
- the zygote may optionally be treated with an agent such as benzamide or 3-amino benzamide which inhibits enzymes such as the nuclear polymerizing ADP-ribosyl transferase; DNA ligase II; deoxynucleotidyl terminal transferase and the repair DNA polymerases.
- an agent such as benzamide or 3-amino benzamide which inhibits enzymes such as the nuclear polymerizing ADP-ribosyl transferase; DNA ligase II; deoxynucleotidyl terminal transferase and the repair DNA polymerases.
- Such agents include ultra-violet light and alkylating agents (dimethylsulphate for example) as well as other agents such as l,3-Bis-(2-chloroethyl)-l-nitrosourea and even low levels of DNAase which are known to introduce strand-breaks.
- the paternal gamete DNA has been degraded.
- the gametes may comprise the combination of (i) an ovum and a sperm, or (ii) an egg cell or other ovule-derived cell capable of functioning thereas, and a pollen grain and/or sperm cell.
- the paternal gamete Prior to fertilization, the paternal gamete may be treated with an agent capable of degrading or otherwise cleaving its chromosomal DNA in response to a specific stimulus provided to the zygote. It is particularly preferred that the paternal gamete has been treated substantially in the dark with a photo-excitable DNA intercalater, and that fertilization is also effected substantially in the dark.
- “dark” is meant, the substantial absence of ultraviolet light and other electromagnetic radiations having a wavelength of from about 0.1 to about l ⁇ m. In particular “dark” means the substantial absence of electromagnetic radiations having a wavelength of from about 350 to 800 nm.
- the DNA intercalater may be an acridine compound, including acridine orange or acridine yellow, or it may be any other suitable compound, for example: ethidium bromide, 6-mercapto purine or propidium iodide.
- the specific stimulus may be visible light or ultraviolet light.
- visible or ultraviolet light is meant electromagnetic radiations having a wavelength of from about 0.1 to about l ⁇ m, and more particularly those radiations having wavelengths within the range of about 100 to 800nm
- the zygote may comprise a substantially haploid genome, or a genome contributed substantially by the maternal gamete.
- the amount of degradation may be chosen by the skilled man, having regard to the amount of intercalater introduced into the DNA and amount of stimulus provided to the thus intercalated DNA.
- Chromosome fragments, optionally comprising genes or gene fragments, originating from the paternal gamete are preferably integrated into chromosomal DNA originating from the maternal gamete. This integration may take place in the zygote in the nuclear part thereof which is derived from the maternal gamete, although the invention also includes the possibility that the integration takes place in the mitochondria or chloroplasts (if present). Such fragments may of course be stably present in the zygote absent such integration.
- the zygote may be treated with any suitable known ploidy increasing agent, either subsequent to degradation of the DNA but prior to the first mitotic division of the zygote, or subsequent to the first mitotic division of the zygote but prior to degradation of the DNA.
- suitable ploidy increasing agents include colchicine, dinitroaniline herbicides such as oryzalin and trifluralin, amiprophos methyl and nitrous oxide.
- the paternal chromosomal DNA prior to its degradation, comprises a suitable marker gene.
- marker genes include genes involved in the generation of a phenotypically identifiable trait, antibiotic resistance-inducing genes, herbicide resistance - inducing genes, and others such as those encoding beta glucuronidase and luciferase.
- the invention also includes an organism, particularly a non-human animal or a plant, resulting from cell division of the zygote according to the present invention.
- the invention still further includes the progeny of the organism, or the seeds of the organism and/or the progeny thereof.
- the invention still further includes a method of producing a viable zygote according to the invention, which has an altered chromosome complement when compared with the wild type, comprising fertilizing a maternal gamete with a paternal gamete, characterized in that in the zygote, chromosomal DNA from one of the gametes is substantially degraded.
- the paternal gamete is treated with a photo-excitable DNA intercalating agent in the dark, fertilization of the maternal gamete takes place in the dark, and that the zygote is subjected to visible or uv light before or after its first mitotic division.
- the invention still further includes a zygote obtainable by the above disclosed method.
- the invention will be further apparent from the following which describes the production of essentially maternal haploid transformed sugar beet plants in which the paternally originating GUS marker gene has been incorporated into the maternal genome as a consequence of the paternal DNA having been selectively destroyed post fertilization.
- PGM-B 2 ml boron-free PGM
- PGM used for sugar beet pollen is defined as: sucrose 300 g/1; CaCl 2 2H 2 O 150 mg 1; H 3 BO 3 100 mg/1; 50mM MES, (pH 6.0)).
- the tube is foiled to prevent light from reaching the pollen. All subsequent operations are performed under conditions of reduced light intensity.
- PGM-B is added so that the total volume is about 10 ml.
- the thus treated pollen is centrifuged at about lOOOrpm for about 5 min (Hereaus Labofuge), the Acridine Orange- containing supernatant is removed and the precipitated pollen is washed with 10 ml PGM-B.
- the thus washed pollen is centrifuged as above, and the precipitate is resuspended in about 0.5-1 ml PGM-B.
- the Acridine Orange treatment is considered successful if thus treated pollen can germinate in the dark but not in the light. Moreover, under a UV-microscope orange colored nuclei are visible in the pollen tubes of the germinating pollen.
- ovules are harvested (in the dark or in very dim light) from the pollinated flowers (normally sugarbeet pollen fertilize the egg cell about 17h post- pollination, after about 21h the zygote is formed and the first mitotic division is about 25h post-pollination) and placed on a suitable haploid embryo induction medium in a petri-dish which is subsequently sealed and covered with foil until exposure to light.
- a suitable haploid embryo induction medium in a petri-dish which is subsequently sealed and covered with foil until exposure to light.
- some of the ovules are exposed to visible light (2000 ⁇ Em "2 S _1 ) from a Nolpi light source at a distance of about 50cm for 15 or 30 min. Following such exposure the petri- dishes are re-sealed, placed in dark at 25°C and the thus exposed ovules are cultured for about 3-6 weeks until harvest of embryos.
- Harvested embryos are transferred to regeneration medium. Developing shoots are cloned on standard sugar beet cloning medium and the thus developed shoots are rooted by transfer to medium containing Indole butyric acid (IBA). Rooted plants are transferred to a greenhouse. The plants are analysed for morphological abnormalities; chromosome number group (flow cytometry); isozyme production; transgenic status (X-Gluc GUS-assay); and glyphosate resistance.
- IBA Indole butyric acid
- Pollen is harvested from plants transgenic for the GUS-marker gene, pooled, treated with Acridine Orange for 60 minutes and washed as described above. This treated pollen is used to pollinate a single CMS-plant. Ovules are harvested 24 hours or four days post-pollination and treated with light as described above. The results demonstrate that acridine Orange loaded pollen can germinate on stigma and grow through the micropyle to the egg cell and fertilize the egg cell to form a viable zygote that can develop into an embryo. Moreover, certain chimeric embryos are found to be GUS-positive in cotyledons, but GUS-negative in root and root-hairs.
- the egg cell has divided at least once meaning that the nucleic acid in the cell(s) of the zygote which are destined to form the root part of the embryo is selectively destabilised by the light treatment. From this particular chimeric embryo, shoots are regenerated and cloned. Some of the shoots consisted of mainly GUS-negative cells, other were mainly GUS-positive. The GUS-positive cells are regenerated into plants and rooted.
- the thus rooted plants are GUS positive in all tissues (including roots) meaning that the observed chimerism is not due to integration of the transgene behind a tissue-specific (shoot) promoter or is otherwise under the control of a shoot specific region on the chromosome, but is due to the late treatment of light to the developing zygote.
- the amount of Acridine Orange per cell of the zygote thus gradually diminishes a the zygote divides.
- ovules are harvested and exposed to different amounts of visible light.
- the amount of light used for degradation of the chemical chromosome inter ⁇ calating complex is regulated individually for each fertilization event so that the amount of light given to any fertilized egg correlates positively with the donor-DNA fragmentation.
- Table 1 summarizes the results of the above treatment. Row A of the Table relates to ovules isolated from unpollinated flowers.
- the present invention enables the production of transformed plants wherein gene transfer from one haploid genome to another (paternal to maternal) occurs thus enabling the production, with or without embryo rescue, of embryos or seeds having a near haploid [or near halved tetraploid] chromosome set.
- the present invention has been exemplified with respect to the production of transformed sugar beet plants transgenic for the paternally originating GUS marker gene, it will be appreciated that it is not limited to plants, and that transformed versions of any organism which results from the mitotic division of a zygote may be produced. Moreover, if it can be determined where the egg cell is located in the ovule, it is possible using the method according to the invention to direct light specifically at the egg cell thus cleaving only DNA contained within this fertilized cell. This leaves the nucleic acids in the central nucleus - which gives rise to endosperm - relatively intact.
- the ovule is loaded with acridine orange
- precise direction of light to only the egg cell will result in a similar situation, but with the degradation of mainly maternally-derived DNA in the zygote.
- the technique can equally well be applied to animals.
- eggs may be collected treated with acridine orange and fertilized with non-treated sperm to facilitate degradation of the maternally originating genome and survival of the paternally originating genome in the zygote.
- the present invention enables the introduction of agronomically important traits (such as nematode, insect or virus resistance) from wild species into cultured distantly related species, with the proviso that the pollen from the wild species is capable of inducing zygote formation in the cultured species.
- agronomically important traits such as nematode, insect or virus resistance
- Genes of interest may be introduced into hitherto difficult to transform crop species by a process involving the introduction of a gene (by known transformation techniques) into relatives distantly related to the difficult to transform species.
- the gene is then introduced into the said crop species by the asymmetric chromosome transfer technique according to the invention. This protocol is especially useful for the introduction of desired traits into difficult to transform of otherwise recalcitrant crops.
- the method according to the invention provides the possibility to transfer chromosomes or chromosome fragments containing the desired genes: (i) from maintainer or restorer lines to male sterile Unes without the loss of male sterile character; or (ii) between maintainer lines and restorer lines such that the desired genes are allelic.
- Numerous medical applications of the present invention include the replacement of mutated or otherwise defective regions of recipient chromosomes at the zygotic level in gametes suspected of containing such defective chromosome regions.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
La présente invention se rapporte à un zygote viable dans lequel l'ADN chromosomique provenant de l'un des gamètes parents a été sensiblement dégradé. L'invention se rapporte également à des organismes, en particulier des plantes, obtenus par division cellulaire du zygote; ainsi qu'à un procédé de production d'un zygote viable comprenant un complément chromosomique modifié par rapport au zygote de phénotype sauvage, ce procédé consistant à féconder un gamète femelle avec un gamète mâle et se caractérisant en ce que, dans le zygote, l'ADN chromosomique provenant de l'un des gamètes est sensiblement dégradé. Le gamète mâle est de préférence traité, dans l'obscurité, au moyen d'un agent d'intercalation d'ADN, la fécondation du gamète femelle s'effectuant également dans l'obscurité, et le zygote étant exposé à une lumière visible et/ou ultraviolette avant ou après sa première division mitotique.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU79394/94A AU7939494A (en) | 1993-10-25 | 1994-10-24 | Viable zygote |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9321975.6 | 1993-10-25 | ||
GB939321975A GB9321975D0 (en) | 1993-10-25 | 1993-10-25 | Improvements in or relating to organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995011967A1 true WO1995011967A1 (fr) | 1995-05-04 |
Family
ID=10744078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1994/003485 WO1995011967A1 (fr) | 1993-10-25 | 1994-10-24 | Zygote viable |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7939494A (fr) |
GB (1) | GB9321975D0 (fr) |
WO (1) | WO1995011967A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002098210A3 (fr) * | 2001-06-05 | 2004-04-15 | Univ Missouri | Procede de doublement des chromosomes |
CN113125227A (zh) * | 2020-12-25 | 2021-07-16 | 上海乐辰生物科技有限公司 | 核型分析用制备高分辨染色体的秋水溶液及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU436645A1 (ru) * | 1973-01-25 | 1974-07-25 | Центральная Ордена Трудового Красного Знамени Генетическая Лаборатория Им.И.В.Мичурина | Способ преодолени нескрещиваемости плодовых культур |
RU2002406C1 (ru) * | 1992-01-16 | 1993-11-15 | Pashchenko Vasilij M | Способ получени мутаций растений |
-
1993
- 1993-10-25 GB GB939321975A patent/GB9321975D0/en active Pending
-
1994
- 1994-10-24 WO PCT/EP1994/003485 patent/WO1995011967A1/fr active Application Filing
- 1994-10-24 AU AU79394/94A patent/AU7939494A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU436645A1 (ru) * | 1973-01-25 | 1974-07-25 | Центральная Ордена Трудового Красного Знамени Генетическая Лаборатория Им.И.В.Мичурина | Способ преодолени нескрещиваемости плодовых культур |
RU2002406C1 (ru) * | 1992-01-16 | 1993-11-15 | Pashchenko Vasilij M | Способ получени мутаций растений |
Non-Patent Citations (13)
Title |
---|
ACTA GENET. SIN., vol. 8, no. 1, 1981, pages 50 - 55 * |
BANGA, S.S., ET AL.: "Gametic gene transfer in Indian mustard (Brassica juncea)", HEREDITY, vol. 53, no. 2, 1984, pages 293 - 298 * |
BIOLOGICAL ABSTRACTS, vol. 73, Philadelphia, PA, US; abstract no. 45541, WU, C., ET AL.: "Carp Cyprinus-carpio gynogenesis with reference to establishing a pure line" * |
BULETINUL ACADEMIEI DE STIINTE A REPUBLICII MOLDAVA, STIINTE BIOLOGICE SI CHIMICE, no. 5, 1992, pages 19 - 23 * |
CHIN, S.-F., ET AL.: "Pollination with irradiated pollen in rice Oryza sativa L.: I. First (M1) generation", HEREDITY, vol. 63, no. 2, 1989, pages 163 - 170 * |
DATABASE CAB CAB INTERNATIONAL, WALLINGFORD, OXON, GB; PASHCHENKO, V.M., ET AL.: "Effects of combined treatment with ultraviolet radiation and sensitizer dyes on germinating pollen" * |
DATABASE WPI Section Ch Week 7525, Derwent World Patents Index; Class C03, AN 75-42189W * |
DATABASE WPI Section PQ Week 9410, Derwent World Patents Index; Class P13, AN 94-080672 * |
MORRISON, R.A., ET AL.: "Haploid plants from tissue culture: new plant varieties in a shortened time frame", BIOTECHNOLOGY, vol. 6, June 1988 (1988-06-01), pages 684 - 690, XP001344669 * |
PANDEY, K.K., ET AL.: "Evidence for gene transfer by the use of sublethally irradiated pollen in Zea mays and theory of ocurrence by chromosome repair through somatic recombination and gene conversion", MOL. GEN. GENET., vol. 191, no. 3, 1983, pages 358 - 365 * |
RU-C-2002406 (PASHCHENKO V M) 15 NOVEMBER 1993 * |
SAUTON, A., ET AL.: "Induction of gynogenetic haploid plants in muskmelon Cucumis-melo L. by use of irradiated pollen", AGRONOMIE, vol. 7, no. 2, 1987, pages 141 - 147, XP008103758, DOI: doi:10.1051/agro:19870209 * |
SHINTAKU, Y., ET AL.: "Chromosomal variation in hybrids between Nicotiana repanda Willd. and N.tabacum L. through pollen and egg-cell irradiation techniques", GENOME, vol. 32, no. 2, April 1989 (1989-04-01), pages 251 - 256 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002098210A3 (fr) * | 2001-06-05 | 2004-04-15 | Univ Missouri | Procede de doublement des chromosomes |
US7135615B2 (en) | 2001-06-05 | 2006-11-14 | The Curators Of The University Of Missouri | Chromosome doubling method |
CN113125227A (zh) * | 2020-12-25 | 2021-07-16 | 上海乐辰生物科技有限公司 | 核型分析用制备高分辨染色体的秋水溶液及应用 |
Also Published As
Publication number | Publication date |
---|---|
GB9321975D0 (en) | 1993-12-15 |
AU7939494A (en) | 1995-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Walbot | Sources and consequences of phenotypic and genotypic plasticity in flowering plants | |
AU2023200393B2 (en) | A Method For Using Plant Heterosis | |
DE69329943T2 (de) | Verfahren zur Introduktion von einem fruchtbarkeitswiederherstellenden Gen und zur Produktion von Brassica F1-Hybriden | |
EP0160692A1 (fr) | Procede de transfert de genes exogenes dans des plantes en utilisant le pollen comme vecteur | |
EP0301316B1 (fr) | Méthode de transfert de gènes dans des plantes | |
McCoy et al. | Interspecific hybridization of perennial Medicago species using ovule-embryo culture | |
CN112322632B (zh) | 基因lam及应用、获得草莓雄性不育系的方法及试剂盒 | |
Krasnyanski et al. | Production of fertile somatic hybrid plants of sunflower and Helianthus giganteus L. by protoplast fusion | |
Finch et al. | Action of triploid inducer (tri) on meiosis in barley (Hordeum vulgare L.) | |
US4840906A (en) | Plant generation method | |
Matsubara et al. | Embryoid and callus formation from microspores by anther culture from July to November in pepper (Capsicum annuum L.) | |
NL8801888A (nl) | Werkwijze voor het vormen van een praktisch zuivere f1-hybridepopulatie van planten. | |
Bernard et al. | Crossing maize with sorghum, Tripsacum and millet: the products and their level of development following pollination | |
Kolesnikova et al. | Haploid biotechnology as a tool for creating a selection material for sugar beets | |
WO1995011967A1 (fr) | Zygote viable | |
JP5734969B2 (ja) | 倍加半数体植物を作出する方法 | |
JPH11512290A (ja) | Polima CMS細胞質を有し、高温及び低温において雄性不稔性である細胞質雄性不稔性Brassica oleracea植物 | |
Wan et al. | Anther culture of maize | |
Kang et al. | A rapid Agrobacterium-mediated transformation method using maize B104 immature embryos | |
US4734369A (en) | Tissue cultures of Lycopersicon spp. | |
WO2002001940A2 (fr) | Procede permettant de produire des vegetaux fertiles a partir de microspores isoles | |
Skálová et al. | Embryo and ovule cultures in Cucumis species and their utilization in interspecific hybridization | |
Nowaczyk | Spontaneous and induced polyembryony in pepper (Capsicum annuum L.) | |
CA2004378C (fr) | Methode pour augmenter la capacite d'une espece vegetale de subir l'androgenese, et produits ainsi obtenus | |
Moemi et al. | An optimized protocol for in vitro regeneration of tropical maize inbred lines through cell suspension and semi-protoplast cultures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |